LLLakshmi Priya Lalitha

Lakshmi Priya Lalitha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lakshmi Priya Lalitha has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of Vitamin D3 Supplementation on Sleep Quality in Deficient Adults: A Randomized Controlled Trial

    by Lakshmi Priya Lalitha, Pradeep Rangaiah, Anish Mehta, Mahendra Javali, Purushottam T. Acharya, Shivaraj Nallur Somanna

    Background: Emerging evidence suggests a link between serum vitamin D3 deficiency and poor sleep quality, but the optimal dosing frequency to improve sleep quality remains unclear. This study investigates the impact of daily versus weekly vitamin D3 supplementation on sleep quality in adults with vitamin D3 deficiency. Methods: This single-center, prospective, single-blinded, randomized controlled trial randomized vitamin D3-deficient adults in a 1:1 ratio to receive either daily supplementation (6000 IU/day for 8 weeks) or weekly supplementation (60,000 IU/week for 8 weeks). Subjective sleep quality was evaluated with the Pittsburg Sleep Quality Index (PSQI) questionnaire at baseline and after 8 weeks. The Wilcoxon signed-rank test and Mann–Whitney U test were used to compare both groups. Results: This study enrolled 87 patients, with 45 in the weekly arm and 42 in the daily arm. The mean age was 39.26 [11.03] years, and 71% ( n = 62) were female. On follow-up, the daily arm showed significant improvements in “duration of sleep” (0.93 [0.65] vs 1.55 [0.75], P = 0.002) and “daytime dysfunction due to sleep” (0.67 [0.57] vs 1.11 [1.15], P = 0.007). In contrast, the weekly arm performed better in the “need medication to sleep” parameter (0.13 [0.50] vs 0.37 [0.54], P = 0.034). However, the daily supplementation arm showed a favorable trend in the PSQI total score (8.46 [3.14] vs 9.93 [2.68], P = 0.024). Conclusion: Daily vitamin D3 supplementation is more effective than weekly supplementation in improving overall sleep quality, sleep duration, and daytime dysfunction in vitamin D3-deficient adults. Trial Registration: Clinical Trial Registry of India (CTRI/2024/01/061970) on 29.1.2024

  • Open Access

    Atrial Cardiopathy in Embolic Strokes of Undetermined Source

    by Lakshmi Priya Lalitha, Pradeep Rangaiah, Anupama V. Hegde, K Harish, Shivaraj N. Somanna, K Navikala, Mahendra Javali, Anish Mehta, Purushottam T. Acharya

    Background: Embolic Strokes of Undetermined Source (ESUS) accounts for about 9–25% of all ischemic strokes. Atrial cardiopathy (AC) is a recently described pathology of the left atrium and is found to be associated with embolic strokes. This study aimed to study the prevalence and outcomes of AC among patients with ESUS. Methods: This is a single-centre, prospective, observational study conducted over a period of 1 year. AC was diagnosed by the presence of any one of the following biomarker using electrocardiogram (P-wave duration ≥110 ms, prolonged PR interval ≥200 ms, P-wave terminal force V1 ≥5000 μV*ms), echocardiogram (left atrial diameter ≥39 mm in men and ≥37 mm in women, left atrial volume index ≥34 ml/m 2 ) or serum (N-terminal-probrain natriuretic peptide [NT-proBNP] ≥250 pg/mL) at baseline among patients with ESUS. All the patients were followed up after 90 days. The study cohort was divided into two groups: ESUS with AC and ESUS without AC. Both groups were compared using the Mann-Whitney U test. Fisher’s exact test was used to identify the parameter associated with recurrent stroke. P 250 pg/mL is the most common biomarker. Abnormal P-wave terminal force in V1 and P-wave duration may be associated with stroke recurrence.

  • Open Access

    Non-Compressive Myelopathy Secondary to Triple Antibody-Positive Primary Antiphospholipid Syndrome

    by Lakshmi Priya Lalitha, Chintalapati Ashrith, Purushottam Acharya, Mahendra Javali, Pradeep Rangaiah, Anish Mehta

    Transverse myelitis is a rare neurological manifestation of antiphospholipid antibody syndrome. Most previously reported cases present with an acute or subacute onset whereas chronic presentations are extremely rare and pose a significant diagnostic challenge. We report a case of middle-aged female with a prior history of unprovoked deep vein thrombosis of the right lower limb who presented with gradually progressive symptoms suggestive of non-compressive cervical myelopathy. Blood investigations revealed a triple-positive antiphospholipid antibodies profile with no clinical or immunological evidence of the commonly associated systemic lupus erythematosus SLE. She was treated with high-dose steroids and mycophenolate mofetil and demonstrated mild to moderate clinical improvement after six months of follow-up.

  • New onset seizures in Octogenarians

    by Lakshmi Priya Lalitha, Ashalatha Radhakrishnan

    Key summary points AbstractSection Aim This study assesses the clinical characteristics and factors linked to seizure recurrence in older individuals (over 85 years) experiencing new-onset seizures. AbstractSection Findings The most common presenting seizure type is generalized tonic-clonic seizure, and stroke is the most common etiology when identified. The majority of the patients have favorable outcomes and achieve seizure freedom with monotherapy alone. Past strokes and the use of anti-seizure medications such as phenytoin and clobazam are factors associated with seizure recurrence. AbstractSection Message This study helps physicians to facilitate targeted diagnostics and initiate appropriate treatment in octogenarians with new-onset seizures.


  • Focal haemorrhage as atypical feature on MRI in progressive multifocal leukoencephalopathy

    by Lakshmi Priya, Mahendra Javali, Purushottam Acharya, Pradeep Rangaiah

    Progressive multifocal leukoencephalopathy (PML) is a severe progressive demyelinating disorder caused by the suppression of cell-mediated immunity and is diagnosed by typical imaging features on MRI and confirmed by the identification of the JC virus on CSF. We present a case of HIV positive adult male who presented with progressive hemiparesis and spastic dysarthria over 3 months duration, and MRI showed white matter T2 hyper, T1 isointense and peripherally diffusion restricting lesion in the right frontoparietal region with an additional focal haemorrhage within the lesion, which misled us away from considering PML. However, repeat imaging showed progression of the lesion and CSF analysis showed John Cunningham (JC) virus, confirming the diagnosis.

  • “Cock-walk” gait and “horseshoe moustache” sign on MRI in inherited hypermanganesemia

    by Ajith Cherian, Lakshmi Priya, K. P. Divya

    Exogenous manganese (Mn) intoxication leads only to neurotoxicity, whereas inherited hypermanganesemia additionally can cause cirrhosis and polycythemia. We report two affected siblings in a family from South India with severe dysarthria, without dysphagia, generalized dystonia, and characteristic “cock-walk” gait which are clinical clues. Genetic study showed homozygous mutation in the first exon of solute carrier family 30 member 10 (SLC30A10) gene (c.134T>C) confirming the diagnosis of inherited hypermanganesaemia with dystonia 1 (HMNDYT1). Characteristic brain MRI finding is involvement of pontine tegmentum on T1 axial images (due to affliction of central tegmental tract [CTT]) with sparing of ventral pons giving rise to “horseshoe moustache” sign. Symmetric hyperintensities in dentate nucleus, globus pallidus, and putamen while relatively sparing caudate nucleus on T1 without signal intensity abnormalities on T2 images are highly suggestive of hypermanganesaemia. Axial diffusion tensor imaging confirmed the “horseshoe moustache” sign to be constituted by the affected CTT. Hypermanganesaemia-induced CTT involvement in T1 needs to be differentiated from the other more common pediatric causes of CTT affliction which are evident on T2 or diffusion weighted images. Identification is crucial as it is a treatable disorder of metal deposition amenable to chelation.